25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Guangzhou LBP Medicine Science & Technology Co Ltd
Buy, Hold or Sell?

Let's analyze Guangzhou LBP Medicine Science & Technology Co Ltd together

I guess you are interested in Guangzhou LBP Medicine Science & Technology Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Guangzhou LBP Medicine Science & Technology Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Guangzhou LBP Medicine Science & Technology Co Ltd

I send you an email if I find something interesting about Guangzhou LBP Medicine Science & Technology Co Ltd.

1. Quick Overview

1.1. Quick analysis of Guangzhou LBP Medicine Science & Technology Co Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Guangzhou LBP Medicine Science & Technology Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.02
When do you have the money?
1 year
How often do you get paid?
52.2%

What is your share worth?

Current worth
¥13.36
Expected worth in 1 year
¥13.48
How sure are you?
73.9%

+ What do you gain per year?

Total Gains per Share
¥0.29
Return On Investment
0.8%

For what price can you sell your share?

Current Price per Share
¥35.20
Expected price per share
¥22.81 - ¥39.50
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Guangzhou LBP Medicine Science & Technology Co Ltd (5 min.)




Live pricePrice per Share (EOD)
¥35.20
Intrinsic Value Per Share
¥8.19 - ¥10.09
Total Value Per Share
¥21.54 - ¥23.45

2.2. Growth of Guangzhou LBP Medicine Science & Technology Co Ltd (5 min.)




Is Guangzhou LBP Medicine Science & Technology Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$171.6m$168.4m$2.1m1.3%

How much money is Guangzhou LBP Medicine Science & Technology Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$1.1m$854.9k$246.6k22.4%
Net Profit Margin6.7%4.6%--

How much money comes from the company's main activities?

2.3. Financial Health of Guangzhou LBP Medicine Science & Technology Co Ltd (5 min.)




2.4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)




  Industry Rankings (Medical Instruments & Supplies)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Guangzhou LBP Medicine Science & Technology Co Ltd?

Welcome investor! Guangzhou LBP Medicine Science & Technology Co Ltd's management wants to use your money to grow the business. In return you get a share of Guangzhou LBP Medicine Science & Technology Co Ltd.

First you should know what it really means to hold a share of Guangzhou LBP Medicine Science & Technology Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Guangzhou LBP Medicine Science & Technology Co Ltd is ¥35.20. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Guangzhou LBP Medicine Science & Technology Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Guangzhou LBP Medicine Science & Technology Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥13.36. Based on the TTM, the Book Value Change Per Share is ¥0.03 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.04 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.04 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Guangzhou LBP Medicine Science & Technology Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.020.1%0.010.0%0.010.0%0.020.1%0.020.1%
Usd Book Value Change Per Share0.020.0%0.000.0%0.010.0%0.060.2%0.080.2%
Usd Dividend Per Share0.000.0%0.010.0%0.010.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.020.1%0.010.0%0.010.0%0.060.2%0.080.2%
Usd Price Per Share2.49-2.68-3.74-3.23-2.81-
Price to Earnings Ratio32.03-92.31--1,068.29--162.90--141.65-
Price-to-Total Gains Ratio133.54--804.99--306.72--241.27--241.27-
Price to Book Ratio1.36-1.47-2.10-1.85-1.61-
Price-to-Total Gains Ratio133.54--804.99--306.72--241.27--241.27-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.83296
Number of shares206
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.00
Usd Book Value Change Per Share0.000.06
Usd Total Gains Per Share0.010.06
Gains per Quarter (206 shares)2.0513.27
Gains per Year (206 shares)8.1853.07
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
153-225143
21076410296
31510146154149
41913227205202
52417309256255
629203811307308
734234613358361
839275415410414
944306217461467
1049337019512520

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%10.02.00.083.3%18.02.00.090.0%21.02.00.091.3%21.02.00.091.3%
Book Value Change Per Share2.02.00.050.0%6.06.00.050.0%13.07.00.065.0%14.07.02.060.9%14.07.02.060.9%
Dividend per Share4.00.00.0100.0%9.00.03.075.0%9.00.011.045.0%12.00.011.052.2%12.00.011.052.2%
Total Gains per Share3.01.00.075.0%7.05.00.058.3%14.06.00.070.0%17.06.00.073.9%17.06.00.073.9%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Guangzhou LBP Medicine Science & Technology Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1170.029+298%0.037+218%0.453-74%0.581-80%
Book Value Per Share--13.36013.282+1%12.973+3%11.646+15%10.502+27%
Current Ratio--8.9217.493+19%5.770+55%8.775+2%7.871+13%
Debt To Asset Ratio--0.0910.096-5%0.109-16%0.110-17%0.113-19%
Debt To Equity Ratio--0.0990.104-6%0.121-18%0.124-21%0.129-23%
Dividend Per Share--0.0190.043-55%0.039-52%0.017+15%0.023-18%
Enterprise Value--1574410553.8401692175388.343-7%2536591320.495-38%2869276691.112-45%2869276691.112-45%
Eps--0.1420.086+65%0.067+113%0.144-1%0.153-7%
Ev To Ebitda Ratio--infinfnan%infnan%infnan%infnan%
Ev To Sales Ratio--3.1593.442-8%5.471-42%6.200-49%6.200-49%
Free Cash Flow Per Share--0.066-0.022+134%0.071-6%-0.077+216%-0.050+175%
Free Cash Flow To Equity Per Share--0.066-0.022+134%0.055+20%0.236-72%0.213-69%
Gross Profit Margin--1.0001.0000%62.352-98%10.716-91%9.198-89%
Intrinsic Value_10Y_max--10.091--------
Intrinsic Value_10Y_min--8.185--------
Intrinsic Value_1Y_max---0.299--------
Intrinsic Value_1Y_min---0.294--------
Intrinsic Value_3Y_max--0.101--------
Intrinsic Value_3Y_min--0.076--------
Intrinsic Value_5Y_max--1.704--------
Intrinsic Value_5Y_min--1.495--------
Market Cap3293582899.200+48%1700125090.8301824804049.748-7%2575841983.515-34%2230561257.781-24%1939618485.027-12%
Net Profit Margin--0.1060.067+59%0.046+131%0.126-15%0.140-24%
Operating Margin----0%-0.0190%0.040-100%0.056-100%
Operating Ratio--1.2611.285-2%1.133+11%0.979+29%0.945+33%
Pb Ratio2.635+48%1.3601.469-7%2.100-35%1.850-26%1.609-15%
Pe Ratio62.058+48%32.03492.310-65%-1068.286+3435%-162.898+609%-141.651+542%
Price Per Share35.200+48%18.17019.503-7%27.205-33%23.546-23%20.474-11%
Price To Free Cash Flow Ratio133.057+48%68.68333.595+104%9.341+635%-5.430+108%-4.722+107%
Price To Total Gains Ratio258.710+48%133.544-804.991+703%-306.721+330%-241.274+281%-241.274+281%
Quick Ratio--4.2373.797+12%4.712-10%7.951-47%7.060-40%
Return On Assets--0.0100.006+65%0.005+112%0.013-23%0.015-35%
Return On Equity--0.0100.006+65%0.005+111%0.014-27%0.017-40%
Total Gains Per Share--0.1360.072+88%0.076+79%0.469-71%0.604-77%
Usd Book Value--171632857.058170637696.896+1%168464001.073+2%151056355.791+14%136167412.845+26%
Usd Book Value Change Per Share--0.0160.004+298%0.005+218%0.062-74%0.080-80%
Usd Book Value Per Share--1.8341.824+1%1.781+3%1.599+15%1.442+27%
Usd Dividend Per Share--0.0030.006-55%0.005-52%0.002+15%0.003-18%
Usd Enterprise Value--216166569.042232335680.819-7%348273988.304-38%393951689.690-45%393951689.690-45%
Usd Eps--0.0190.012+65%0.009+113%0.020-1%0.021-7%
Usd Free Cash Flow--849652.818-285908.722+134%882812.834-4%-1038799.611+222%-682370.050+180%
Usd Free Cash Flow Per Share--0.009-0.003+134%0.010-6%-0.011+216%-0.007+175%
Usd Free Cash Flow To Equity Per Share--0.009-0.003+134%0.008+20%0.032-72%0.029-69%
Usd Market Cap452208932.060+48%233427174.971250545596.030-7%353663104.337-34%306256060.693-24%266309617.994-12%
Usd Price Per Share4.833+48%2.4952.678-7%3.735-33%3.233-23%2.811-11%
Usd Profit--1821710.7971101612.323+65%854985.452+113%1847949.293-1%1966549.075-7%
Usd Revenue--17108961.42917006708.954+1%16735569.501+2%15629372.547+9%15084678.818+13%
Usd Total Gains Per Share--0.0190.010+88%0.010+79%0.064-71%0.083-77%
 EOD+4 -4MRQTTM+28 -9YOY+22 -165Y+15 -2410Y+13 -26

3.3 Fundamental Score

Let's check the fundamental score of Guangzhou LBP Medicine Science & Technology Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1562.058
Price to Book Ratio (EOD)Between0-12.635
Net Profit Margin (MRQ)Greater than00.106
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than14.237
Current Ratio (MRQ)Greater than18.921
Debt to Asset Ratio (MRQ)Less than10.091
Debt to Equity Ratio (MRQ)Less than10.099
Return on Equity (MRQ)Greater than0.150.010
Return on Assets (MRQ)Greater than0.050.010
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Guangzhou LBP Medicine Science & Technology Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose31.500
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About Guangzhou LBP Medicine Science & Technology Co Ltd

Guangzhou LBP Medicine Science & Technology Co., Ltd. engages in the research, development, and production of pathological diagnosis products in China. The company offers pathological diagnostic reagents and ancillary equipment that consists of liquid-based cytology products, including liquid-based cytology production machines and automatic sample transfer machines; polymerase chain reaction products, such as human papillomavirus gene test kits, sample preservation solutions, and automatic nucleic acid molecular hybridization instruments; fluorescence in situ hybridization products comprising auto-fish instruments, and AML1/ETO, EGFR, BCR/ABL fusion, PML/RARA, and TOP2A gene testing kits; and digital pathology products pathological medical image analysis processing systems, real-time microscopic visual field sharing systems, and bingli scanner. It also provides immunohistochemistry products including automatic antigen repair instrument and automatic immunocytochemical staining machine, as well as conversional pathology equipment. The company was founded in 2005 and is based in Guangzhou, China.

Fundamental data was last updated by Penke on 2025-02-15 01:07:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is fair priced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Guangzhou LBP Medicine Science & Technology Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Guangzhou LBP Medicine Science & Technology Co Ltd to the Medical Instruments & Supplies industry mean.
  • A Net Profit Margin of 10.6% means that ¥0.11 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Guangzhou LBP Medicine Science & Technology Co Ltd:

  • The MRQ is 10.6%. The company is making a huge profit. +2
  • The TTM is 6.7%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ10.6%TTM6.7%+3.9%
TTM6.7%YOY4.6%+2.1%
TTM6.7%5Y12.6%-5.9%
5Y12.6%10Y14.0%-1.5%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ10.6%4.9%+5.7%
TTM6.7%4.6%+2.1%
YOY4.6%6.5%-1.9%
5Y12.6%6.8%+5.8%
10Y14.0%7.3%+6.7%
4.3.1.2. Return on Assets

Shows how efficient Guangzhou LBP Medicine Science & Technology Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Guangzhou LBP Medicine Science & Technology Co Ltd to the Medical Instruments & Supplies industry mean.
  • 1.0% Return on Assets means that Guangzhou LBP Medicine Science & Technology Co Ltd generated ¥0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Guangzhou LBP Medicine Science & Technology Co Ltd:

  • The MRQ is 1.0%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.6%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.0%TTM0.6%+0.4%
TTM0.6%YOY0.5%+0.1%
TTM0.6%5Y1.3%-0.7%
5Y1.3%10Y1.5%-0.2%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0%0.9%+0.1%
TTM0.6%0.8%-0.2%
YOY0.5%1.5%-1.0%
5Y1.3%1.9%-0.6%
10Y1.5%1.7%-0.2%
4.3.1.3. Return on Equity

Shows how efficient Guangzhou LBP Medicine Science & Technology Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Guangzhou LBP Medicine Science & Technology Co Ltd to the Medical Instruments & Supplies industry mean.
  • 1.0% Return on Equity means Guangzhou LBP Medicine Science & Technology Co Ltd generated ¥0.01 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Guangzhou LBP Medicine Science & Technology Co Ltd:

  • The MRQ is 1.0%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 0.6%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.0%TTM0.6%+0.4%
TTM0.6%YOY0.5%+0.1%
TTM0.6%5Y1.4%-0.8%
5Y1.4%10Y1.7%-0.3%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0%2.0%-1.0%
TTM0.6%1.6%-1.0%
YOY0.5%2.7%-2.2%
5Y1.4%3.3%-1.9%
10Y1.7%3.3%-1.6%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Guangzhou LBP Medicine Science & Technology Co Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Guangzhou LBP Medicine Science & Technology Co Ltd is operating .

  • Measures how much profit Guangzhou LBP Medicine Science & Technology Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Guangzhou LBP Medicine Science & Technology Co Ltd to the Medical Instruments & Supplies industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Guangzhou LBP Medicine Science & Technology Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-1.9%+1.9%
TTM-5Y4.0%-4.0%
5Y4.0%10Y5.6%-1.6%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.5%-7.5%
TTM-6.9%-6.9%
YOY-1.9%8.8%-10.7%
5Y4.0%9.4%-5.4%
10Y5.6%9.3%-3.7%
4.3.2.2. Operating Ratio

Measures how efficient Guangzhou LBP Medicine Science & Technology Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • An Operation Ratio of 1.26 means that the operating costs are ¥1.26 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Guangzhou LBP Medicine Science & Technology Co Ltd:

  • The MRQ is 1.261. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.285. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.261TTM1.285-0.024
TTM1.285YOY1.133+0.152
TTM1.2855Y0.979+0.306
5Y0.97910Y0.945+0.033
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2611.089+0.172
TTM1.2851.094+0.191
YOY1.1331.001+0.132
5Y0.9791.018-0.039
10Y0.9450.991-0.046
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Guangzhou LBP Medicine Science & Technology Co Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Guangzhou LBP Medicine Science & Technology Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A Current Ratio of 8.92 means the company has ¥8.92 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Guangzhou LBP Medicine Science & Technology Co Ltd:

  • The MRQ is 8.921. The company is very able to pay all its short-term debts. +2
  • The TTM is 7.493. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ8.921TTM7.493+1.428
TTM7.493YOY5.770+1.723
TTM7.4935Y8.775-1.282
5Y8.77510Y7.871+0.904
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ8.9212.030+6.891
TTM7.4932.069+5.424
YOY5.7702.471+3.299
5Y8.7752.654+6.121
10Y7.8712.606+5.265
4.4.3.2. Quick Ratio

Measures if Guangzhou LBP Medicine Science & Technology Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Guangzhou LBP Medicine Science & Technology Co Ltd to the Medical Instruments & Supplies industry mean.
  • A Quick Ratio of 4.24 means the company can pay off ¥4.24 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Guangzhou LBP Medicine Science & Technology Co Ltd:

  • The MRQ is 4.237. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.797. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.237TTM3.797+0.440
TTM3.797YOY4.712-0.915
TTM3.7975Y7.951-4.154
5Y7.95110Y7.060+0.891
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ4.2370.917+3.320
TTM3.7971.061+2.736
YOY4.7121.231+3.481
5Y7.9511.482+6.469
10Y7.0601.607+5.453
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Guangzhou LBP Medicine Science & Technology Co Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Guangzhou LBP Medicine Science & Technology Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Guangzhou LBP Medicine Science & Technology Co Ltd to Medical Instruments & Supplies industry mean.
  • A Debt to Asset Ratio of 0.09 means that Guangzhou LBP Medicine Science & Technology Co Ltd assets are financed with 9.1% credit (debt) and the remaining percentage (100% - 9.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Guangzhou LBP Medicine Science & Technology Co Ltd:

  • The MRQ is 0.091. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.096. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.091TTM0.096-0.005
TTM0.096YOY0.109-0.013
TTM0.0965Y0.110-0.014
5Y0.11010Y0.113-0.002
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0910.385-0.294
TTM0.0960.358-0.262
YOY0.1090.346-0.237
5Y0.1100.365-0.255
10Y0.1130.376-0.263
4.5.4.2. Debt to Equity Ratio

Measures if Guangzhou LBP Medicine Science & Technology Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Guangzhou LBP Medicine Science & Technology Co Ltd to the Medical Instruments & Supplies industry mean.
  • A Debt to Equity ratio of 9.9% means that company has ¥0.10 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Guangzhou LBP Medicine Science & Technology Co Ltd:

  • The MRQ is 0.099. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.104. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.099TTM0.104-0.006
TTM0.104YOY0.121-0.017
TTM0.1045Y0.124-0.020
5Y0.12410Y0.129-0.004
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0990.576-0.477
TTM0.1040.538-0.434
YOY0.1210.520-0.399
5Y0.1240.592-0.468
10Y0.1290.665-0.536
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Guangzhou LBP Medicine Science & Technology Co Ltd generates.

  • Above 15 is considered overpriced but always compare Guangzhou LBP Medicine Science & Technology Co Ltd to the Medical Instruments & Supplies industry mean.
  • A PE ratio of 32.03 means the investor is paying ¥32.03 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Guangzhou LBP Medicine Science & Technology Co Ltd:

  • The EOD is 62.058. Based on the earnings, the company is expensive. -2
  • The MRQ is 32.034. Based on the earnings, the company is overpriced. -1
  • The TTM is 92.310. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD62.058MRQ32.034+30.024
MRQ32.034TTM92.310-60.276
TTM92.310YOY-1,068.286+1,160.596
TTM92.3105Y-162.898+255.208
5Y-162.89810Y-141.651-21.248
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD62.05814.200+47.858
MRQ32.03415.824+16.210
TTM92.31016.455+75.855
YOY-1,068.28620.055-1,088.341
5Y-162.89820.884-183.782
10Y-141.65125.800-167.451
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Guangzhou LBP Medicine Science & Technology Co Ltd:

  • The EOD is 133.057. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 68.683. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The TTM is 33.595. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD133.057MRQ68.683+64.374
MRQ68.683TTM33.595+35.088
TTM33.595YOY9.341+24.254
TTM33.5955Y-5.430+39.025
5Y-5.43010Y-4.722-0.708
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD133.05710.229+122.828
MRQ68.6839.744+58.939
TTM33.5958.083+25.512
YOY9.341-0.086+9.427
5Y-5.4305.972-11.402
10Y-4.7222.509-7.231
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Guangzhou LBP Medicine Science & Technology Co Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A PB ratio of 1.36 means the investor is paying ¥1.36 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Guangzhou LBP Medicine Science & Technology Co Ltd:

  • The EOD is 2.635. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.360. Based on the equity, the company is underpriced. +1
  • The TTM is 1.469. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.635MRQ1.360+1.275
MRQ1.360TTM1.469-0.109
TTM1.469YOY2.100-0.632
TTM1.4695Y1.850-0.381
5Y1.85010Y1.609+0.241
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD2.6352.602+0.033
MRQ1.3602.619-1.259
TTM1.4692.733-1.264
YOY2.1002.787-0.687
5Y1.8503.856-2.006
10Y1.6094.376-2.767
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets1,375,772
Total Liabilities125,715
Total Stockholder Equity1,274,419
 As reported
Total Liabilities 125,715
Total Stockholder Equity+ 1,274,419
Total Assets = 1,375,772

Assets

Total Assets1,375,772
Total Current Assets660,884
Long-term Assets714,888
Total Current Assets
Cash And Cash Equivalents 44,891
Short-term Investments 65,158
Net Receivables 248,717
Inventory 87,267
Other Current Assets 189,807
Total Current Assets  (as reported)660,884
Total Current Assets  (calculated)635,839
+/- 25,045
Long-term Assets
Property Plant Equipment 300,763
Goodwill 26,462
Intangible Assets 30,766
Long-term Assets Other 109,279
Long-term Assets  (as reported)714,888
Long-term Assets  (calculated)467,270
+/- 247,618

Liabilities & Shareholders' Equity

Total Current Liabilities74,079
Long-term Liabilities51,635
Total Stockholder Equity1,274,419
Total Current Liabilities
Short Long Term Debt 7,000
Accounts payable 36,320
Other Current Liabilities 2,102
Total Current Liabilities  (as reported)74,079
Total Current Liabilities  (calculated)45,422
+/- 28,657
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt3,927
Long-term Liabilities Other 3,918
Long-term Liabilities  (as reported)51,635
Long-term Liabilities  (calculated)7,845
+/- 43,790
Total Stockholder Equity
Retained Earnings 389,712
Total Stockholder Equity (as reported)1,274,419
Total Stockholder Equity (calculated)389,712
+/- 884,707
Other
Capital Stock93,568
Common Stock Shares Outstanding 93,568
Net Invested Capital 1,281,419
Net Working Capital 586,805
Property Plant and Equipment Gross 300,763



6.2. Balance Sheets Structured

Currency in CNY. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
> Total Assets 
0
498,229
0
537,962
519,530
581,357
1,239,496
1,292,251
1,317,293
1,301,105
1,335,202
1,365,684
1,374,586
1,356,918
1,374,749
1,392,784
1,371,910
1,362,754
1,381,770
1,399,931
1,360,362
1,365,687
1,375,772
1,375,7721,365,6871,360,3621,399,9311,381,7701,362,7541,371,9101,392,7841,374,7491,356,9181,374,5861,365,6841,335,2021,301,1051,317,2931,292,2511,239,496581,357519,530537,9620498,2290
   > Total Current Assets 
0
337,597
0
365,975
347,338
387,465
1,049,408
1,062,916
1,073,812
1,025,228
1,019,204
909,175
859,306
777,742
652,310
595,076
509,847
543,188
550,482
567,570
525,460
608,176
660,884
660,884608,176525,460567,570550,482543,188509,847595,076652,310777,742859,306909,1751,019,2041,025,2281,073,8121,062,9161,049,408387,465347,338365,9750337,5970
       Cash And Cash Equivalents 
0
75,986
0
85,698
63,569
30,392
545,163
635,271
663,103
511,377
431,575
217,676
312,618
254,403
102,072
90,911
70,817
58,456
64,397
67,682
48,309
57,019
44,891
44,89157,01948,30967,68264,39758,45670,81790,911102,072254,403312,618217,676431,575511,377663,103635,271545,16330,39263,56985,698075,9860
       Short-term Investments 
0
64,270
0
84,877
100,698
161,079
283,318
210,462
175,544
259,862
327,464
419,421
254,328
221,269
236,909
175,537
107,042
103,188
61,205
52,564
49,122
57,278
65,158
65,15857,27849,12252,56461,205103,188107,042175,537236,909221,269254,328419,421327,464259,862175,544210,462283,318161,079100,69884,877064,2700
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
222,569
230,622
234,700
236,165
232,608
231,122
250,623
235,547
240,636
244,911
248,717
248,717244,911240,636235,547250,623231,122232,608236,165234,700230,622222,569000000000000
       Other Current Assets 
0
173,411
0
174,857
157,864
168,367
192,363
192,137
207,032
223,365
228,834
231,509
8,558
8,075
8,473
9,117
8,902
50,074
80,264
111,821
70,808
136,540
189,807
189,807136,54070,808111,82180,26450,0748,9029,1178,4738,0758,558231,509228,834223,365207,032192,137192,363168,367157,864174,8570173,4110
   > Long-term Assets 
0
160,632
0
171,986
172,192
193,893
190,088
229,334
243,481
275,877
315,999
456,509
515,280
579,175
722,439
797,707
862,063
819,566
831,288
832,361
834,902
757,511
714,888
714,888757,511834,902832,361831,288819,566862,063797,707722,439579,175515,280456,509315,999275,877243,481229,334190,088193,893172,192171,9860160,6320
       Property Plant Equipment 
0
123,952
0
133,485
133,352
152,208
154,304
193,759
207,495
237,538
245,733
276,650
292,908
315,979
317,787
327,035
325,320
321,759
321,778
314,378
310,816
306,584
300,763
300,763306,584310,816314,378321,778321,759325,320327,035317,787315,979292,908276,650245,733237,538207,495193,759154,304152,208133,352133,4850123,9520
       Goodwill 
0
8,087
0
8,087
8,087
8,087
8,087
8,087
8,087
9,626
9,626
29,521
29,521
29,521
29,521
29,521
29,521
29,521
29,521
26,462
26,462
26,462
26,462
26,46226,46226,46226,46229,52129,52129,52129,52129,52129,52129,52129,5219,6269,6268,0878,0878,0878,0878,0878,08708,0870
       Intangible Assets 
0
5,812
0
5,922
5,793
5,980
5,873
5,772
5,658
5,682
5,832
5,853
5,739
6,148
6,841
7,247
8,832
12,329
16,537
22,637
24,864
26,119
30,766
30,76626,11924,86422,63716,53712,3298,8327,2476,8416,1485,7395,8535,8325,6825,6585,7725,8735,9805,7935,92205,8120
> Total Liabilities 
0
95,012
0
93,334
64,938
105,328
89,882
124,667
123,009
134,536
144,636
155,959
146,288
139,383
149,478
170,447
146,974
141,166
142,721
161,626
116,600
126,574
125,715
125,715126,574116,600161,626142,721141,166146,974170,447149,478139,383146,288155,959144,636134,536123,009124,66789,882105,32864,93893,334095,0120
   > Total Current Liabilities 
0
60,942
0
57,762
29,064
69,103
53,065
87,411
84,686
94,560
103,636
106,839
94,874
87,617
95,719
114,264
92,108
86,843
90,506
110,335
65,938
76,615
74,079
74,07976,61565,938110,33590,50686,84392,108114,26495,71987,61794,874106,839103,63694,56084,68687,41153,06569,10329,06457,762060,9420
       Short-term Debt 
0
0
0
0
0
0
0
0
1,368
1,996
1,254
9,538
9,136
9,218
17,667
17,564
17,710
0
0
0
0
0
0
00000017,71017,56417,6679,2189,1369,5381,2541,9961,36800000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
9,136
9,218
17,667
17,564
17,710
8,957
15,121
23,203
3,197
9,782
7,000
7,0009,7823,19723,20315,1218,95717,71017,56417,6679,2189,136000000000000
       Accounts payable 
0
27,104
0
30,988
17,920
42,801
30,671
55,894
61,360
65,026
77,169
49,760
45,934
42,456
40,315
32,591
30,358
36,252
40,984
37,140
28,040
36,843
36,320
36,32036,84328,04037,14040,98436,25230,35832,59140,31542,45645,93449,76077,16965,02661,36055,89430,67142,80117,92030,988027,1040
       Other Current Liabilities 
0
29,689
0
19,766
9,069
19,288
13,021
22,613
13,180
20,989
19,263
47,540
39,803
35,943
37,737
64,110
44,040
2,598
1,864
2,277
2,326
2,275
2,102
2,1022,2752,3262,2771,8642,59844,04064,11037,73735,94339,80347,54019,26320,98913,18022,61313,02119,2889,06919,766029,6890
   > Long-term Liabilities 
0
34,070
0
35,572
35,874
36,225
36,817
37,256
38,322
39,976
41,001
49,121
51,414
51,766
53,758
56,183
54,866
54,324
52,215
51,291
50,662
49,959
51,635
51,63549,95950,66251,29152,21554,32454,86656,18353,75851,76651,41449,12141,00139,97638,32237,25636,81736,22535,87435,572034,0700
> Total Stockholder Equity
0
400,937
0
443,280
453,160
475,876
1,149,601
1,167,971
1,195,103
1,172,672
1,197,007
1,204,003
1,223,627
1,216,195
1,227,915
1,228,605
1,239,187
1,241,516
1,264,081
1,263,611
1,273,276
1,269,010
1,274,419
1,274,4191,269,0101,273,2761,263,6111,264,0811,241,5161,239,1871,228,6051,227,9151,216,1951,223,6271,204,0031,197,0071,172,6721,195,1031,167,9711,149,601475,876453,160443,2800400,9370
   Common Stock
0
70,000
0
70,000
70,000
70,000
93,340
93,340
93,340
93,340
93,340
93,340
93,340
93,340
93,340
93,340
93,340
0
0
0
0
0
0
00000093,34093,34093,34093,34093,34093,34093,34093,34093,34093,34093,34070,00070,00070,000070,0000
   Retained Earnings Total Equity00000000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000000
   Capital Surplus 00000000000000000000000
   Treasury Stock00000000000000000000000
   Other Stockholders Equity 
0
159,729
0
163,248
163,248
163,248
779,854
787,483
787,950
767,439
768,139
777,244
777,244
779,432
782,714
787,649
790,786
0
0
0
0
0
0
000000790,786787,649782,714779,432777,244777,244768,139767,439787,950787,483779,854163,248163,248163,2480159,7290



6.3. Balance Sheets

Currency in CNY. All numbers in thousands.




6.4. Cash Flows

Currency in CNY. All numbers in thousands.




6.5. Income Statements

Currency in CNY. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in CNY. All numbers in thousands.

Gross Profit (+$)
totalRevenue497,291
Cost of Revenue-156,674
Gross Profit340,617340,617
 
Operating Income (+$)
Gross Profit340,617
Operating Expense-477,120
Operating Income20,171-136,503
 
Operating Expense (+$)
Research Development62,687
Selling General Administrative200,714
Selling And Marketing Expenses0
Operating Expense477,120263,401
 
Net Interest Income (+$)
Interest Income8,796
Interest Expense-808
Other Finance Cost-141
Net Interest Income7,847
 
Pretax Income (+$)
Operating Income20,171
Net Interest Income7,847
Other Non-Operating Income Expenses0
Income Before Tax (EBT)16,84920,171
EBIT - interestExpense = -808
40,057
40,865
Interest Expense808
Earnings Before Interest and Taxes (EBIT)017,657
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax16,849
Tax Provision--4,170
Net Income From Continuing Ops21,01921,019
Net Income40,057
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-7,847
 

Technical Analysis of Guangzhou LBP Medicine Science & Technology Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Guangzhou LBP Medicine Science & Technology Co Ltd. The general trend of Guangzhou LBP Medicine Science & Technology Co Ltd is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Guangzhou LBP Medicine Science & Technology Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Guangzhou LBP Medicine Science & Technology Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 39.50.

The bearish price targets are: 26.58 > 25.39 > 22.81.

Tweet this
Guangzhou LBP Medicine Science & Technology Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Guangzhou LBP Medicine Science & Technology Co Ltd. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Guangzhou LBP Medicine Science & Technology Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Guangzhou LBP Medicine Science & Technology Co Ltd.

Guangzhou LBP Medicine Science & Technology Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartGuangzhou LBP Medicine Science & Technology Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Guangzhou LBP Medicine Science & Technology Co Ltd. The current adx is .

Guangzhou LBP Medicine Science & Technology Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Guangzhou LBP Medicine Science & Technology Co Ltd.

Guangzhou LBP Medicine Science & Technology Co Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Guangzhou LBP Medicine Science & Technology Co Ltd.

Guangzhou LBP Medicine Science & Technology Co Ltd Daily Relative Strength Index (RSI) ChartGuangzhou LBP Medicine Science & Technology Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Guangzhou LBP Medicine Science & Technology Co Ltd.

Guangzhou LBP Medicine Science & Technology Co Ltd Daily Stochastic Oscillator ChartGuangzhou LBP Medicine Science & Technology Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Guangzhou LBP Medicine Science & Technology Co Ltd.

Guangzhou LBP Medicine Science & Technology Co Ltd Daily Commodity Channel Index (CCI) ChartGuangzhou LBP Medicine Science & Technology Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Guangzhou LBP Medicine Science & Technology Co Ltd.

Guangzhou LBP Medicine Science & Technology Co Ltd Daily Chande Momentum Oscillator (CMO) ChartGuangzhou LBP Medicine Science & Technology Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Guangzhou LBP Medicine Science & Technology Co Ltd.

Guangzhou LBP Medicine Science & Technology Co Ltd Daily Williams %R ChartGuangzhou LBP Medicine Science & Technology Co Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Guangzhou LBP Medicine Science & Technology Co Ltd.

Guangzhou LBP Medicine Science & Technology Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Guangzhou LBP Medicine Science & Technology Co Ltd.

Guangzhou LBP Medicine Science & Technology Co Ltd Daily Average True Range (ATR) ChartGuangzhou LBP Medicine Science & Technology Co Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Guangzhou LBP Medicine Science & Technology Co Ltd.

Guangzhou LBP Medicine Science & Technology Co Ltd Daily On-Balance Volume (OBV) ChartGuangzhou LBP Medicine Science & Technology Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Guangzhou LBP Medicine Science & Technology Co Ltd.

Guangzhou LBP Medicine Science & Technology Co Ltd Daily Money Flow Index (MFI) ChartGuangzhou LBP Medicine Science & Technology Co Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Guangzhou LBP Medicine Science & Technology Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-09-30STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-08ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-28WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-31STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-06STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-11-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-11-11BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-11-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-15STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-11-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-06CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-12-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-12-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-12-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-12-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-25STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-12-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-08MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-01-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-01-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-01-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-01-27STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-02-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-07WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-02-10STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-02-14BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-17ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-18STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-24STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-02-25STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside

6.3. Candlestick Patterns

Guangzhou LBP Medicine Science & Technology Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Guangzhou LBP Medicine Science & Technology Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose31.500
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Guangzhou LBP Medicine Science & Technology Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Guangzhou LBP Medicine Science & Technology Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Guangzhou LBP Medicine Science & Technology Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Guangzhou LBP Medicine Science & Technology Co Ltd

I send you an email if I find something interesting about Guangzhou LBP Medicine Science & Technology Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Guangzhou LBP Medicine Science & Technology Co Ltd.

Receive notifications about Guangzhou LBP Medicine Science & Technology Co Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.